Clinical Trials Directory

Trials / Completed

CompletedNCT01427296

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2,154 (actual)
Sponsor
Bausch Health Americas, Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.

Conditions

Interventions

TypeNameDescription
DRUGPolyethylene glycolHalfLytely and Bisacodyl Tablet Bowel Prep Kit, administered as 1 bisacodyl tablet followed by HalfLytely oral solution in a total liquid volume of approximately 2 L
DRUGOral sodium phosphate solutionOsmoPrep tablets (48 g), administered as 32 total tablets in a total liquid volume of approximately 2 L

Timeline

Start date
2011-09-16
Primary completion
2014-03-11
Completion
2014-12-09
First posted
2011-09-01
Last updated
2018-01-18
Results posted
2018-01-18

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01427296. Inclusion in this directory is not an endorsement.